| Primary |
| Sciatica |
50.0% |
| Gout |
25.0% |
| Pain |
25.0% |
|
| Thrombocytopenia |
50.0% |
| Vomiting |
50.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
22.2% |
| Gout |
15.5% |
| Product Used For Unknown Indication |
12.9% |
| Bronchopneumopathy |
7.8% |
| Hypertension |
7.5% |
| Urinary Tract Infection |
4.7% |
| Unevaluable Event |
3.9% |
| Diabetes Mellitus |
3.7% |
| Erysipelas |
3.0% |
| Chondrocalcinosis |
2.4% |
| Infection |
2.2% |
| Gastroduodenal Ulcer |
1.9% |
| Pain |
1.9% |
| Gastritis |
1.7% |
| Hyperuricaemia |
1.7% |
| Pneumonia |
1.7% |
| Cholecystitis |
1.3% |
| Crystal Arthropathy |
1.3% |
| Dyslipidaemia |
1.3% |
| Helicobacter Gastritis |
1.3% |
|
| Vomiting |
29.0% |
| Renal Failure Acute |
12.2% |
| Septic Shock |
9.2% |
| Neutropenia |
8.4% |
| Red Blood Cell Count Decreased |
6.1% |
| Pyrexia |
5.3% |
| Rhabdomyolysis |
3.8% |
| Thrombocytopenia |
3.8% |
| Toxic Skin Eruption |
3.8% |
| Renal Failure |
3.1% |
| Haematuria |
1.5% |
| Hallucination |
1.5% |
| Renal Failure Chronic |
1.5% |
| Shock |
1.5% |
| Shock Haemorrhagic |
1.5% |
| Tongue Disorder |
1.5% |
| Transaminases Increased |
1.5% |
| Underdose |
1.5% |
| Urinary Tract Infection |
1.5% |
| White Blood Cell Count Increased |
1.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.6% |
| Gout |
13.8% |
| Product Used For Unknown Indication |
10.0% |
| Hypertension |
8.3% |
| Palindromic Rheumatism |
7.6% |
| Cardiac Disorder |
5.7% |
| Sepsis |
4.5% |
| Hiv Infection |
4.0% |
| Rheumatoid Arthritis |
3.8% |
| Osteoporosis |
3.1% |
| Multiple Myeloma |
2.9% |
| Prostate Cancer |
2.9% |
| Atrial Fibrillation |
2.6% |
| Pain |
2.6% |
| Hyperuricaemia |
2.1% |
| Breast Cancer |
1.9% |
| Diabetes Mellitus |
1.9% |
| Epilepsy |
1.9% |
| Gastritis Prophylaxis |
1.9% |
| Osteoarthritis |
1.9% |
|
| Renal Failure Acute |
12.2% |
| Vomiting |
9.5% |
| Lung Disorder |
8.1% |
| Stevens-johnson Syndrome |
8.1% |
| Sepsis |
6.8% |
| Weight Decreased |
6.8% |
| Urinary Retention |
5.4% |
| Cytolytic Hepatitis |
4.1% |
| General Physical Health Deterioration |
4.1% |
| Somnolence |
4.1% |
| Subdural Haematoma |
4.1% |
| Syncope |
4.1% |
| Systemic Inflammatory Response Syndrome |
4.1% |
| Angina Pectoris |
2.7% |
| Febrile Bone Marrow Aplasia |
2.7% |
| Gynaecomastia |
2.7% |
| Hepatocellular Injury |
2.7% |
| Hypocalcaemia |
2.7% |
| Leukocytoclastic Vasculitis |
2.7% |
| Nausea |
2.7% |
|
| Interacting |
| Gout |
17.1% |
| Drug Use For Unknown Indication |
15.4% |
| Product Used For Unknown Indication |
11.4% |
| Renal Transplant |
10.6% |
| Dyslipidaemia |
6.5% |
| Heart Transplant |
4.9% |
| Arthralgia |
4.1% |
| Hypertension |
4.1% |
| Hiv Infection |
3.3% |
| Nephrotic Syndrome |
3.3% |
| Congenital Hand Malformation |
2.4% |
| Gouty Tophus |
2.4% |
| Hypercholesterolaemia |
2.4% |
| Pain |
2.4% |
| Amyloidosis |
1.6% |
| Arrhythmia |
1.6% |
| Arthritis |
1.6% |
| Bronchopneumopathy |
1.6% |
| Hyperuricaemia |
1.6% |
| Organising Pneumonia |
1.6% |
|
| Vomiting |
23.7% |
| Rhabdomyolysis |
21.1% |
| Weight Decreased |
10.5% |
| Thrombocytopenia |
7.9% |
| Pancytopenia |
5.3% |
| Renal Failure Acute |
5.3% |
| Shock |
5.3% |
| Shock Haemorrhagic |
5.3% |
| Fall |
2.6% |
| Gait Disturbance |
2.6% |
| Normochromic Normocytic Anaemia |
2.6% |
| Splenomegaly |
2.6% |
| Toxic Skin Eruption |
2.6% |
| Ureteric Anastomosis Complication |
2.6% |
|
